{"gene":"SIX2","run_date":"2026-04-28T20:42:07","timeline":{"discoveries":[{"year":2008,"finding":"Six2-expressing cap mesenchyme cells represent a multipotent nephron progenitor population that self-renews throughout kidney development; Six2 functions cell-autonomously to maintain progenitor status, as cap mesenchyme cells lacking Six2 activity contribute to ectopic nephron tubules via a Wnt9b-dependent inductive signal.","method":"Genetic lineage tracing (Six2-Cre), clonal analysis, conditional knockout, organ culture","journal":"Cell stem cell","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal genetic methods (lineage tracing, clonal analysis, conditional KO) with clear cellular phenotype; highly cited foundational study","pmids":["18682239"],"is_preprint":false},{"year":2006,"finding":"Six2 is required to maintain metanephric mesenchyme progenitor cells in an undifferentiated state by opposing Wnt inductive signals from the ureteric bud; functional inactivation of Six2 results in premature and ectopic epithelial differentiation and depletion of the progenitor pool, causing renal hypoplasia; gain of Six2 function prevents epithelial differentiation in organ culture.","method":"Loss-of-function mouse genetics, gain-of-function organ culture assay","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 2 — reciprocal gain/loss-of-function with defined cellular phenotype; replicated by multiple labs","pmids":["17036046"],"is_preprint":false},{"year":2012,"finding":"Six2 and β-catenin co-occupy shared cis-regulatory modules at Wnt4 and Fgf8 loci in nephron progenitors; Six2 and Lef/Tcf factors form a regulatory complex that promotes progenitor maintenance, while entry of β-catenin into this complex promotes nephrogenesis; Six2-dependent self-renewal and canonical Wnt/β-catenin-directed commitment operate through shared gene regulatory networks.","method":"Chromatin immunoprecipitation (ChIP), transcriptional profiling, in vitro and in vivo co-occupancy analysis, Lef/Tcf binding site mutagenesis","journal":"Developmental cell","confidence":"High","confidence_rationale":"Tier 1-2 — ChIP with functional validation and mutagenesis, strong mechanistic resolution","pmids":["22902740"],"is_preprint":false},{"year":2014,"finding":"Eya1 interacts with Six2 and Myc to control self-renewing nephron progenitor cell activity; Six2 mediates translocation of Eya1 to the nucleus, where Eya1 uses its threonine phosphatase activity to control Myc phosphorylation/dephosphorylation in progenitor cells.","method":"Co-immunoprecipitation, conditional knockout, cell fate tracing, nuclear translocation assay, phosphatase activity assay","journal":"Developmental cell","confidence":"High","confidence_rationale":"Tier 1-2 — Co-IP, enzymatic activity assay, and in vivo conditional KO with defined molecular and cellular phenotype","pmids":["25458011"],"is_preprint":false},{"year":2004,"finding":"Six2 activates expression of the Gdnf gene through two binding sites in the Gdnf promoter that resemble homeobox consensus sequences; Six2 possesses a transcriptional activation domain in its C-terminus and nuclear localization determinants in its Six domain; Six2 also binds and activates its own 930 bp promoter fragment.","method":"Promoter-reporter assay, binding site identification, transgenic LacZ reporter mice, protein domain analysis","journal":"Mechanisms of development","confidence":"Medium","confidence_rationale":"Tier 2-3 — promoter binding and activation assays with transgenic validation, single lab","pmids":["15327782"],"is_preprint":false},{"year":2014,"finding":"Six2 is required to maintain Osr1 expression in the undifferentiated cap mesenchyme; Osr1 and Six2 act synergistically to prevent premature differentiation; Osr1 (but not Six2) enhances TCF interaction with Groucho family co-repressors, stabilizing TCF-Groucho repressor complexes to antagonize Wnt-directed nephrogenic differentiation.","method":"Conditional knockout, protein interaction co-IP, Wnt4 enhancer reporter assay in vivo, epistasis","journal":"Development (Cambridge, England)","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal methods (KO, Co-IP, reporter assay in vivo) with defined pathway placement","pmids":["24598167"],"is_preprint":false},{"year":2016,"finding":"Notch signaling promotes differentiation of nephron progenitors by downregulating Six2; Notch signaling is necessary and sufficient for Six2 downregulation; nephron progenitors lacking Notch signaling fail to differentiate into any nephron segments.","method":"Conditional gain- and loss-of-function mouse genetics, immunofluorescence","journal":"Development (Cambridge, England)","confidence":"High","confidence_rationale":"Tier 2 — reciprocal gain/loss-of-function with clear epistatic relationship and cellular phenotype","pmids":["27633993"],"is_preprint":false},{"year":2014,"finding":"Six2 promotes breast cancer metastasis by repressing E-cadherin expression through transcriptional upregulation of Zeb2 (partly via a microRNA-mediated mechanism) and by stimulating promoter methylation of the Cdh1 gene; E-cadherin downregulation is required for Six2-enhanced soft agar growth and in vivo metastasis.","method":"Overexpression/knockdown, methylation assay, in vivo metastasis model, epistasis rescue experiment","journal":"Cancer research","confidence":"Medium","confidence_rationale":"Tier 2-3 — multiple functional assays with epigenetic mechanistic follow-up, single lab","pmids":["25348955"],"is_preprint":false},{"year":2019,"finding":"Six2 directly binds the Sox2 Srr2 enhancer, promoting Sox2 expression and downstream Nanog expression, thereby establishing a cancer stem cell program that enables metastatic colonization in triple-negative breast cancer models.","method":"ChIP, overexpression/knockdown, enhancer reporter assay, in vivo metastasis model","journal":"Cancer research","confidence":"Medium","confidence_rationale":"Tier 2 — ChIP with functional validation in multiple TNBC models, single lab","pmids":["30606720"],"is_preprint":false},{"year":2008,"finding":"Six2 is a direct downstream target of Hoxa2 in vivo; ectopic expression of Six2 in the absence of Hoxa2 contributes to the Hoxa2 mutant phenotype; Six2 acts redundantly downstream of Hoxa2 and mediates Hoxa2 control over the insulin-like growth factor pathway during branchial arch development.","method":"Genetic epistasis, in vivo loss-of-function, ectopic expression","journal":"Development (Cambridge, England)","confidence":"Medium","confidence_rationale":"Tier 2 — genetic epistasis with in vivo functional validation, single lab","pmids":["18321982"],"is_preprint":false},{"year":2009,"finding":"A single enhancer upstream of the Six2 coding sequence is responsible for both activation by Hox11 proteins in the developing kidney and repression by Hoxa2 in branchial arch and facial mesenchyme; differential activity is conferred by protein domains N- and C-terminal to the homeodomain, not by homeodomain differences; DNA-binding activity is required for both activation and repression.","method":"In vivo enhancer analysis, domain-swap mutagenesis, transgenic reporter mice","journal":"Developmental biology","confidence":"Medium","confidence_rationale":"Tier 2 — in vivo enhancer dissection with mutagenesis, single lab","pmids":["19716816"],"is_preprint":false},{"year":2015,"finding":"LIF activates STAT signaling, which binds a Stat consensus sequence in the Six2 proximal promoter to sustain SIX2 levels in metanephric mesenchyme progenitors; ROCKi attenuates LIF-induced differentiation activity of JNK; LIF/ROCKi combination upregulates Slug expression and activates YAP to maintain SIX2, PAX2, and SALL1.","method":"Promoter-reporter assay, ChIP (STAT binding), pathway inhibition, culture expansion model","journal":"Stem cell reports","confidence":"Medium","confidence_rationale":"Tier 2-3 — STAT binding to Six2 promoter demonstrated by ChIP with functional rescue, single lab","pmids":["26321142"],"is_preprint":false},{"year":2016,"finding":"Six2 activity is required for formation of the pyloric sphincter by regulating a gene network including Bmp4, Bmpr1b, Nkx2.5, Sox9, and Gremlin in mammals.","method":"Loss-of-function mouse genetics, gene expression analysis","journal":"Developmental biology","confidence":"Medium","confidence_rationale":"Tier 2 — KO with defined phenotypic readout and downstream target identification, single lab","pmids":["19660448"],"is_preprint":false},{"year":2016,"finding":"Six2 transcription factor mediates the protective effects of GDNF on damaged dopaminergic neurons by directly binding the CAGCTG promoter sequence of Smurf1 and regulating its expression, which in turn modulates p53 levels; the Akt1/Eya1/Six2 signaling cascade controls GDNF transcription in MES23.5 DA cells by direct Six2 binding to the GDNF promoter.","method":"ChIP-seq, ChIP-qPCR, knockdown/overexpression, in vivo 6-OHDA lesion model","journal":"Cell death & disease","confidence":"Medium","confidence_rationale":"Tier 2 — ChIP-seq with functional validation in vivo, single lab","pmids":["27148690"],"is_preprint":false},{"year":2019,"finding":"MES23.5 DA cells respond to early 6-OHDA injury by activating an Akt1/Eya1/Six2 signaling pathway; activated Akt1 phosphorylates Eya1, which then decreases Six2 phosphorylation; dephosphorylated Six2 promotes GDNF transcription by directly binding the GDNF promoter, conferring neuroprotection.","method":"ChIP-qPCR, phosphorylation assays, knockdown/overexpression, cell viability assays","journal":"Journal of molecular neuroscience : MN","confidence":"Medium","confidence_rationale":"Tier 2-3 — ChIP-qPCR with phosphorylation cascade characterization, single lab","pmids":["31720997"],"is_preprint":false},{"year":2021,"finding":"Eya1 and Six2 interact with the Brg1-based SWI/SNF chromatin-remodeling complex during kidney development; Brg1 occupies a distal enhancer of Eya1 driving nephron progenitor-specific expression; Brg1 enrichment to distal intronic enhancers of Pbx1 and a proximal promoter of Mycn requires Six2 activity, and these Brg1/Six2-bound enhancers govern nephron progenitor-specific expression.","method":"Co-immunoprecipitation (tagged knock-in), genome-wide ChIP, enhancer reporter assay in vivo, conditional knockout","journal":"Journal of the American Society of Nephrology : JASN","confidence":"High","confidence_rationale":"Tier 1-2 — tagged knock-in CoIP with genome-wide ChIP and in vivo enhancer validation, multiple orthogonal methods","pmids":["34716243"],"is_preprint":false},{"year":2021,"finding":"SIX2 knockdown in human pancreatic islets impairs glucose-stimulated insulin secretion, cytoplasmic calcium flux, and mitochondrial respiration; SIX2 directly regulates the expression of genes governing β-cell insulin processing, glucose sensing, and electrophysiology, as determined by chromatin accessibility studies.","method":"shRNA knockdown, ATAC-seq (chromatin accessibility), functional secretion assays, transcriptome profiling","journal":"Genes & development","confidence":"Medium","confidence_rationale":"Tier 2 — multiple functional assays with chromatin accessibility mapping, single lab","pmids":["33446570"],"is_preprint":false},{"year":2020,"finding":"SIX2 regulates functional maturation of stem cell-derived β cells; knockout or knockdown of SIX2 drastically limits glucose-stimulated insulin secretion, cytoplasmic calcium flux, and mitochondrial respiration, and reduces expression of key β-cell functional genes.","method":"KD/KO in hESC-derived SC-β cells, static and dynamic insulin secretion assays, calcium imaging, Seahorse metabolic assay","journal":"Cell reports","confidence":"Medium","confidence_rationale":"Tier 2 — multiple orthogonal functional readouts with KD/KO, single lab","pmids":["32460030"],"is_preprint":false},{"year":2017,"finding":"Six2 marks a dynamic subset of second heart field progenitors whose descendants are successively allocated to regions of the heart from the right ventricle to the pulmonary trunk; global ablation of Six2+ progenitors results in right ventricular hypoplasia and pulmonary atresia; early-stage ablation of a small subset causes adult-onset cardiac hypertrophy; Six2 expression in cardiac progenitors depends partly on Shh signaling.","method":"Genetic lineage tracing, conditional cell ablation, Shh deletion epistasis","journal":"Cell reports","confidence":"Medium","confidence_rationale":"Tier 2 — genetic lineage tracing and ablation with defined cardiac phenotypes, single lab","pmids":["28122228"],"is_preprint":false},{"year":2017,"finding":"SIX2 expression in prostate cancer promotes a stem-like to epithelial cell state switch via the Wnt/β-catenin signaling pathway; SIX2 depletion in androgen-independent PC-3 cells reduces nuclear β-catenin and decreases cancer-related properties including proliferation, colony formation, and metastasis in vitro and in vivo.","method":"SIX2 knockdown, chromatin accessibility (ATAC-seq), in vitro and in vivo functional assays, nuclear β-catenin measurement","journal":"Nucleic acids research","confidence":"Medium","confidence_rationale":"Tier 2 — ATAC-seq with functional in vitro and in vivo validation, single lab","pmids":["38554106"],"is_preprint":false},{"year":2019,"finding":"Six2 directly binds the promoters of CYP4Z1 and CYP4Z2P to activate the ceRNA network between them, thereby activating the downstream PI3K/Akt and ERK1/2 pathways and maintaining breast cancer stemness.","method":"ChIP-seq, RNA-seq, lentiviral overexpression/knockdown, in vitro and in vivo stemness assays","journal":"Journal of hematology & oncology","confidence":"Medium","confidence_rationale":"Tier 2 — ChIP-seq with pathway validation, single lab","pmids":["30832689"],"is_preprint":false},{"year":2010,"finding":"Six2 inactivation causes premature fusion of cranial base bones due to reduced chondrocyte proliferation and increased terminal differentiation; gain-of-function Six2 promotes cartilage development and growth, indicating Six2 controls general regulators of chondrocyte differentiation.","method":"Loss-of-function mouse genetics, gain-of-function experiments, histological analysis of chondrocyte differentiation","journal":"Developmental biology","confidence":"Medium","confidence_rationale":"Tier 2 — reciprocal loss/gain-of-function with defined cellular phenotype, single lab","pmids":["20515681"],"is_preprint":false},{"year":2018,"finding":"In Lowe syndrome patient-derived kidney cells (OCRL1 mutant), Six2 is substantially retained in the Golgi complex with reduced nuclear localization; OCRL1 knockout in HK2 cells recapitulates both ciliogenesis defects and Six2 retention in the Golgi, indicating OCRL1-mediated phosphoinositide regulation controls Six2 nuclear trafficking.","method":"iPSC differentiation, OCRL1 KO, immunofluorescence subcellular localization, ciliogenesis assay","journal":"PloS one","confidence":"Medium","confidence_rationale":"Tier 2-3 — localization with functional consequence in disease-relevant model, replicated in two cell systems","pmids":["29444177"],"is_preprint":false},{"year":2025,"finding":"TRIM21 acts as an E3 ubiquitin ligase that binds to SIX2 via its PRY-SPRY domain and catalyzes K48-type ubiquitination at lysine residues K82, K89, and K97, promoting SIX2 degradation via the ubiquitin-proteasome pathway; this modification attenuates breast cancer stemness and metastasis; SIX2 transcriptionally activates LGSN through direct binding to its promoter.","method":"Co-IP, ubiquitination assay, site-specific mutagenesis (K82/89/97 residues), proteasome inhibitor rescue, ChIP, gain/loss-of-function","journal":"Oncogene","confidence":"Medium","confidence_rationale":"Tier 1-2 — biochemical ubiquitination assay with mutagenesis and functional validation, single lab","pmids":["40954199"],"is_preprint":false},{"year":2017,"finding":"Six2 in Six2 heterozygotes paradoxically increases nephron progenitor proliferation (elevated EdU labeling, increased MYC protein and MYC target gene transcription) and final nephron number, demonstrating that Six2's role in progenitor proliferation versus self-renewal is separable by dosage.","method":"Quantitative morphometry, EdU labeling, Western blot, transcriptional profiling, genetic epistasis with Fgf20 KO","journal":"Kidney international","confidence":"Medium","confidence_rationale":"Tier 2 — multiple quantitative methods with epistasis, single lab","pmids":["29217079"],"is_preprint":false},{"year":2022,"finding":"Six1 and Six2 have divergent biochemical properties: forced expression of Six1 fails to rescue Six2-deficient kidney phenotype; Six1 mediates Eya1 nuclear translocation and inhibits premature epithelialization but fails to rescue proliferation defects and cell death caused by Six2 knockout; genome-wide binding shows Six1 selectively occupies a small subset of Six2 target sites.","method":"Conditional rescue genetics, genome-wide ChIP, cell proliferation/death assays, nuclear translocation assay","journal":"Frontiers in cell and developmental biology","confidence":"Medium","confidence_rationale":"Tier 2 — genome-wide binding comparison with genetic rescue experiment, single lab","pmids":["35178390"],"is_preprint":false},{"year":2021,"finding":"Six2 transcriptionally activates DDIT4, leading to mTOR inhibition, autophagy induction, and a shift from M1 to M2 microglial polarization; M2-polarized microglia release exosomes enriched in miR-3470b that suppress GREM1 in dopaminergic neurons, potentiating TGF-β signaling and rescuing neuronal apoptosis.","method":"RNA-seq, ChIP-qPCR, miRNA sequencing, exosome isolation/transfer, in vitro and in vivo (MPTP mouse) functional assays","journal":"CNS neuroscience & therapeutics","confidence":"Low","confidence_rationale":"Tier 3 — complex mechanism in single lab study, no independent replication","pmids":["41700504"],"is_preprint":false},{"year":2024,"finding":"SIX2 directly regulates METTL9 expression (CUT&Tag); METTL9 binds SLC7A11 (Co-IP) to enhance its stability and reduce ferroptosis, thereby conferring sorafenib resistance in HCC cells; this SIX2-METTL9-SLC7A11 axis operates independently of the GPX4 pathway.","method":"CUT&Tag, Co-IP, overexpression/knockdown, ferroptosis assays, in vivo mouse tumor model","journal":"NPJ precision oncology","confidence":"Low","confidence_rationale":"Tier 3 — single lab, indirect pathway with multiple steps, limited mechanistic validation of each step","pmids":["40523929"],"is_preprint":false},{"year":2019,"finding":"Six2 directly binds the Sox2 enhancer to promote Sox2 expression and RCC cell stemness, forming a Six2/Sox2 axis; overexpression of Sox2 rescues the inhibitory effects of Six2 knockdown on RCC stemness.","method":"ChIP, overexpression/knockdown rescue, spheroid formation assay","journal":"FEBS open bio","confidence":"Low","confidence_rationale":"Tier 3 — single lab, ChIP without mutagenesis or independent replication","pmids":["31420918"],"is_preprint":false},{"year":2021,"finding":"Six2 transcriptionally activates GDNF in dopaminergic cells and forms a transcription complex with Smarcd1 (a SWI/SNF complex member); Smarcd1 is recruited to the 2840-2933 bp region of the GDNF promoter via Six2; knockdown of Smarcd1 inhibits Six2-mediated GDNF expression and increases apoptosis of injured DA neurons.","method":"LC-ESI-ITMS/MS (interactome screen), Co-IP, ChIP, overexpression/knockdown, cell viability assay","journal":"Neuroscience letters","confidence":"Low","confidence_rationale":"Tier 3 — Co-IP and ChIP from single lab with functional follow-up, no independent validation","pmids":["34233203"],"is_preprint":false},{"year":2019,"finding":"Zeb1 promotes Six2 promoter activity (luciferase assay) and Six2 expression in metanephric mesenchyme cells; Zeb1 and Six2 coregulate cell proliferation and apoptosis.","method":"Dual-luciferase assay, Western blot, RT-PCR, knockdown/overexpression, EdU and flow cytometry assays","journal":"International journal of molecular sciences","confidence":"Low","confidence_rationale":"Tier 3 — single lab, single method (luciferase) for transcriptional regulation","pmids":["27509493"],"is_preprint":false},{"year":2017,"finding":"TGFβ type II receptor (TβRII) promotes Six2 expression through Smad3-mediated transcriptional regulation; Smad3 transcriptionally targets Six2 (bioinformatics + luciferase assay); knockdown of TβRII reduces Six2 expression and proliferation, and overexpression of Six2 partially rescues the proliferation defect.","method":"Luciferase assay, RT-PCR, Western blot, EdU proliferation assay, knockdown rescue","journal":"International journal of molecular sciences","confidence":"Low","confidence_rationale":"Tier 3 — single method for transcriptional link (luciferase), single lab, no ChIP validation","pmids":["28420207"],"is_preprint":false},{"year":2026,"finding":"EYA4 interacts with SIX2 to promote expression of p21 and accelerate cellular senescence in a p53-dependent manner; this effect is independent of EYA4 phosphatase activity.","method":"Co-IP, knockdown/overexpression, phosphatase-deficient mutant, promoter reporter assay, senescence assays","journal":"Advanced biotechnology","confidence":"Low","confidence_rationale":"Tier 3 — Co-IP with functional follow-up, single lab, single study","pmids":["41991886"],"is_preprint":false},{"year":2024,"finding":"SIX2 directly binds the promoter of SIX2/PFN2; SIX2 directly activates PFN2 expression, and PFN2 in turn promotes SIX2 mRNA stability by recruiting RNA-binding protein YBX-1, activating the downstream MAPK/JNK pathway to enhance gastric cancer cell stemness.","method":"ChIP, RNA stability assay, IP-MS, Co-IP, JNK pathway inhibition, gain/loss-of-function","journal":"Journal of translational medicine","confidence":"Low","confidence_rationale":"Tier 3 — multiple methods but complex multi-step mechanism from single lab, no replication","pmids":["39256760"],"is_preprint":false}],"current_model":"SIX2 is a homeodomain transcription factor that cell-autonomously maintains multipotent nephron progenitor cells in an undifferentiated state by forming regulatory complexes with Lef/Tcf factors (and co-occupying target loci with β-catenin) to suppress Wnt-directed differentiation; it acts downstream of Hox genes and upstream of Eya1/Myc, directly activates target gene promoters (Gdnf, Smurf1, Sox2, Pax9, LGSN) through sequence-specific DNA binding, interacts with the Brg1-SWI/SNF chromatin-remodeling complex, and is subject to post-translational regulation including Eya1-mediated nuclear translocation, phosphorylation control, and TRIM21-mediated K48-ubiquitination leading to proteasomal degradation."},"narrative":{"teleology":[{"year":2004,"claim":"Establishing that SIX2 is a sequence-specific transcriptional activator resolved the basic molecular activity of the protein: it binds homeodomain-like elements in the Gdnf promoter and its own promoter, and carries a C-terminal activation domain.","evidence":"Promoter-reporter assays, binding-site identification, and transgenic LacZ reporter mice","pmids":["15327782"],"confidence":"Medium","gaps":["No genome-wide binding map; target specificity versus other SIX family members unknown","Activation domain boundaries not precisely mapped"]},{"year":2006,"claim":"Demonstrating that Six2 loss causes premature epithelial differentiation and progenitor depletion, while gain-of-function blocks differentiation, established SIX2 as the key maintenance factor for nephron progenitors opposing Wnt-directed nephrogenesis.","evidence":"Loss-of-function mouse genetics and gain-of-function organ culture","pmids":["17036046"],"confidence":"High","gaps":["Molecular targets through which SIX2 opposes Wnt signaling not yet identified","Whether SIX2 acts cell-autonomously not formally demonstrated"]},{"year":2008,"claim":"Lineage tracing and clonal analysis proved that SIX2-expressing cells are a multipotent, self-renewing nephron progenitor population and that SIX2 functions cell-autonomously, resolving the cellular identity of the progenitor pool.","evidence":"Six2-Cre genetic lineage tracing, clonal analysis, conditional knockout, organ culture","pmids":["18682239"],"confidence":"High","gaps":["Mechanism of self-renewal versus differentiation switch at the chromatin level unresolved","Relationship to other progenitor markers (Osr1, Sall1) not delineated"]},{"year":2008,"claim":"Placing Six2 as a direct downstream target of Hoxa2 during branchial arch development revealed that SIX2 operates in a broader Hox-regulated developmental hierarchy beyond the kidney.","evidence":"Genetic epistasis and ectopic expression in Hoxa2-mutant mice","pmids":["18321982"],"confidence":"Medium","gaps":["Direct Hox binding sites in Six2 regulatory region not mapped","Six2 targets in branchial arch mesenchyme unknown"]},{"year":2009,"claim":"Dissecting a single Six2 enhancer that is activated by Hox11 in kidney and repressed by Hoxa2 in face showed that tissue-specific Six2 expression is governed by flanking Hox protein domains rather than homeodomain DNA-binding specificity.","evidence":"In vivo enhancer analysis with domain-swap mutagenesis in transgenic reporter mice","pmids":["19716816"],"confidence":"Medium","gaps":["Cofactors mediating activation versus repression at the shared enhancer not identified","Whether this enhancer is sufficient for all Six2 kidney expression not tested"]},{"year":2010,"claim":"Loss-of-function and gain-of-function studies in the cranial base demonstrated that SIX2 controls chondrocyte proliferation and opposes terminal differentiation, extending its progenitor-maintenance role to skeletal development.","evidence":"Six2-null and gain-of-function mouse genetics with histological chondrocyte analysis","pmids":["20515681"],"confidence":"Medium","gaps":["Direct transcriptional targets in chondrocytes not identified","Relationship to Wnt or other signaling pathways in this context unknown"]},{"year":2012,"claim":"ChIP and co-occupancy analysis showed that SIX2 and β-catenin bind shared cis-regulatory elements at Wnt4/Fgf8 through Lef/Tcf factors, revealing that progenitor self-renewal and Wnt-directed differentiation operate through the same gene regulatory network with opposing transcriptional outcomes.","evidence":"ChIP, transcriptional profiling, Lef/Tcf binding site mutagenesis in vivo","pmids":["22902740"],"confidence":"High","gaps":["How β-catenin entry into the SIX2–Lef/Tcf complex switches output from maintenance to differentiation is mechanistically unclear","Genome-wide extent of SIX2–β-catenin co-occupancy not fully mapped"]},{"year":2014,"claim":"Identifying the Eya1–Six2–Myc interaction established a phosphatase-dependent signaling axis within the progenitor nucleus: Eya1 uses its threonine phosphatase activity on Myc, and Six2 mediates Eya1 nuclear import, linking post-translational modification to progenitor self-renewal.","evidence":"Co-immunoprecipitation, conditional knockout, phosphatase activity assay, nuclear translocation assay","pmids":["25458011"],"confidence":"High","gaps":["Phosphorylation sites on Myc targeted by Eya1 not mapped","Whether SIX2-dependent Eya1 nuclear translocation requires direct physical interaction or an intermediary not resolved"]},{"year":2014,"claim":"Demonstrating that Osr1 and Six2 synergistically prevent differentiation—with Osr1 specifically stabilizing TCF–Groucho repressor complexes—dissected the division of labor among transcription factors maintaining the progenitor state.","evidence":"Conditional knockout, Co-IP, Wnt4 enhancer reporter in vivo, epistasis","pmids":["24598167"],"confidence":"High","gaps":["Whether Six2 directly stabilizes TCF–Groucho or acts independently not resolved","Functional redundancy between Six2 and Osr1 at the chromatin level not tested"]},{"year":2014,"claim":"Showing that SIX2 represses E-cadherin via Zeb2 upregulation and Cdh1 promoter methylation to drive breast cancer metastasis revealed that SIX2 reactivates developmental EMT programs in cancer.","evidence":"Overexpression/knockdown, methylation assays, in vivo metastasis model, epistasis rescue","pmids":["25348955"],"confidence":"Medium","gaps":["Whether SIX2 directly binds Zeb2 regulatory elements or acts indirectly via miRNAs not fully resolved","Generalizability beyond breast cancer cell lines not established"]},{"year":2016,"claim":"Notch signaling was shown to be necessary and sufficient for SIX2 downregulation during nephron progenitor differentiation, placing Notch as an upstream off-switch for the SIX2-maintained progenitor state.","evidence":"Conditional gain- and loss-of-function Notch pathway genetics in mouse kidney","pmids":["27993993"],"confidence":"High","gaps":["Whether Notch directly represses Six2 transcription or acts through intermediary factors not determined","Interplay between Notch and Wnt signals at the Six2 locus not clarified"]},{"year":2016,"claim":"ChIP-based identification of Smurf1 and GDNF as direct SIX2 targets in dopaminergic neurons, regulated through an Akt1/Eya1/Six2 phosphorylation cascade, extended the SIX2 functional repertoire to neuroprotection.","evidence":"ChIP-seq, ChIP-qPCR, knockdown/overexpression, in vivo 6-OHDA lesion model","pmids":["27148690"],"confidence":"Medium","gaps":["In vivo relevance of Six2 in dopaminergic neuron survival under physiological conditions not established","Structural basis of Eya1-mediated Six2 dephosphorylation unknown"]},{"year":2017,"claim":"Genetic lineage tracing identified SIX2-expressing cells as a dynamic subset of second heart field progenitors whose progressive allocation builds the right ventricle and pulmonary trunk, demonstrating a cardiac developmental role.","evidence":"Six2-Cre lineage tracing, conditional cell ablation, Shh deletion epistasis","pmids":["28122228"],"confidence":"Medium","gaps":["Transcriptional targets of SIX2 in cardiac progenitors unknown","Whether SIX2 is required cell-autonomously in heart progenitors not tested"]},{"year":2017,"claim":"Haploinsufficiency studies revealed that reducing Six2 dosage paradoxically increases progenitor proliferation and final nephron number via elevated MYC, demonstrating that Six2's self-renewal and proliferation-control functions are separable by gene dosage.","evidence":"Quantitative morphometry, EdU labeling, Western blot, transcriptional profiling, Fgf20 epistasis","pmids":["29217079"],"confidence":"Medium","gaps":["Mechanism by which reduced Six2 elevates MYC not determined","Whether this dosage effect is relevant to human nephron endowment variation unknown"]},{"year":2019,"claim":"ChIP demonstrated SIX2 directly binds the Sox2 Srr2 enhancer to activate a Sox2→Nanog stemness cascade in triple-negative breast cancer, establishing a direct transcriptional mechanism for SIX2-driven cancer stem cell maintenance.","evidence":"ChIP, enhancer reporter, overexpression/knockdown, in vivo metastasis model in TNBC","pmids":["30606720"],"confidence":"Medium","gaps":["Whether SIX2 occupancy at Sox2 enhancer requires cofactors (e.g., Eya family) in cancer cells not tested","Relevance to non-breast cancer contexts not established"]},{"year":2020,"claim":"Functional studies in stem cell–derived β cells and human islets demonstrated that SIX2 is required for glucose-stimulated insulin secretion, calcium flux, and mitochondrial respiration, revealing an essential role in mature β-cell function distinct from its developmental progenitor role.","evidence":"KD/KO in hESC-derived SC-β cells and primary human islets, dynamic insulin secretion, calcium imaging, Seahorse assay, ATAC-seq","pmids":["32460030","33446570"],"confidence":"Medium","gaps":["Direct SIX2 target genes mediating metabolic and electrophysiological effects in β cells not fully characterized","Whether SIX2 loss affects β-cell identity or only function not resolved"]},{"year":2021,"claim":"Identifying SIX2 interaction with the Brg1-SWI/SNF complex and showing that Six2 is required for Brg1 recruitment to nephron progenitor enhancers established a chromatin-remodeling mechanism for SIX2-dependent transcriptional activation.","evidence":"Tagged knock-in Co-IP, genome-wide ChIP, in vivo enhancer reporter, conditional knockout","pmids":["34716243"],"confidence":"High","gaps":["Whether SIX2 directly contacts Brg1 or acts through Eya1 as a bridge not resolved","Genome-wide set of SIX2-dependent SWI/SNF-remodeled loci not comprehensively mapped"]},{"year":2022,"claim":"Genome-wide binding comparison between Six1 and Six2 showed that Six1 occupies only a small subset of Six2 target sites and fails to rescue proliferation and survival defects in Six2-null kidneys, establishing that paralog-specific binding underlies non-redundant functions.","evidence":"Conditional rescue genetics, genome-wide ChIP, cell proliferation/death assays","pmids":["35178390"],"confidence":"Medium","gaps":["Sequence or structural determinants of SIX2-specific binding not identified","Cofactor differences that could explain selective occupancy not explored"]},{"year":2025,"claim":"Biochemical identification of TRIM21 as the E3 ligase catalyzing K48-ubiquitination at K82/K89/K97 of SIX2 established the first defined proteolytic regulatory mechanism controlling SIX2 protein levels.","evidence":"Co-IP, in vitro ubiquitination assay, K-to-R mutagenesis, proteasome inhibitor rescue","pmids":["40954199"],"confidence":"Medium","gaps":["Signals or conditions triggering TRIM21-mediated SIX2 degradation not identified","Whether this pathway operates in normal development or only in cancer contexts not tested","No structural model of the TRIM21–SIX2 interface"]},{"year":null,"claim":"A structural basis for SIX2 DNA-binding specificity versus other SIX family members, the complete set of direct transcriptional targets in each progenitor context, and the signaling logic integrating Wnt, Notch, and Eya1 phosphatase inputs at the SIX2 locus remain unresolved.","evidence":"","pmids":[],"confidence":"High","gaps":["No crystal or cryo-EM structure of SIX2 DNA-binding or protein-interaction domains","Genome-wide direct target validation across developmental and disease contexts incomplete","Quantitative signaling model integrating Wnt, Notch, and phosphorylation inputs on SIX2 activity not constructed"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0003677","term_label":"DNA binding","supporting_discovery_ids":[2,4,8,13,15,23]},{"term_id":"GO:0140110","term_label":"transcription regulator activity","supporting_discovery_ids":[1,2,4,8,13,15,16,23]}],"localization":[{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[3,4,15,22]}],"pathway":[{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[2,5,6,19]},{"term_id":"R-HSA-1266738","term_label":"Developmental Biology","supporting_discovery_ids":[0,1,9,10,18,21]},{"term_id":"R-HSA-74160","term_label":"Gene expression (Transcription)","supporting_discovery_ids":[2,4,15,16]},{"term_id":"R-HSA-4839726","term_label":"Chromatin organization","supporting_discovery_ids":[15]}],"complexes":["Brg1-SWI/SNF complex","SIX2–Lef/Tcf complex"],"partners":["EYA1","SMARCA4","SMARCD1","CTNNB1","LEF1","TRIM21","OSR1","EYA4"],"other_free_text":[]},"mechanistic_narrative":"SIX2 is a homeodomain transcription factor that maintains multipotent progenitor populations in an undifferentiated, self-renewing state, most extensively characterized in nephron progenitors of the developing kidney but also operative in cardiac, craniofacial, and pancreatic β-cell contexts. In nephron progenitors, SIX2 opposes Wnt9b/β-catenin–directed epithelial differentiation by co-occupying cis-regulatory modules at target loci (Wnt4, Fgf8) together with Lef/Tcf factors and by recruiting the Brg1-SWI/SNF chromatin-remodeling complex to progenitor-specific enhancers [PMID:22902740, PMID:34716243]. SIX2 possesses a C-terminal transcriptional activation domain and directly activates promoters of Gdnf, Smurf1, Sox2, and other targets through sequence-specific DNA binding, and its activity is controlled post-translationally by Eya1-mediated dephosphorylation facilitating nuclear translocation and by TRIM21-catalyzed K48-linked ubiquitination targeting it for proteasomal degradation [PMID:15327782, PMID:25458011, PMID:40954199]. In cancer contexts, SIX2 reactivates stem-cell programs—including Sox2, E-cadherin repression via Zeb2, and PI3K/Akt signaling—to promote metastasis and therapy resistance [PMID:25348955, PMID:30606720]."},"prefetch_data":{"uniprot":{"accession":"Q9NPC8","full_name":"Homeobox protein SIX2","aliases":["Sine oculis homeobox homolog 2"],"length_aa":291,"mass_kda":32.3,"function":"Transcription factor that plays an important role in the development of several organs, including kidney, skull and stomach. During kidney development, maintains cap mesenchyme multipotent nephron progenitor cells in an undifferentiated state by opposing the inductive signals emanating from the ureteric bud and cooperates with WNT9B to promote renewing progenitor cells proliferation. Acts through its interaction with TCF7L2 and OSR1 in a canonical Wnt signaling independent manner preventing transcription of differentiation genes in cap mesenchyme such as WNT4. Also acts independently of OSR1 to activate expression of many cap mesenchyme genes, including itself, GDNF and OSR1. During craniofacial development plays a role in growth and elongation of the cranial base through regulation of chondrocyte differentiation. During stomach organogenesis, controls pyloric sphincter formation and mucosal growth through regulation of a gene network including NKX2-5, BMPR1B, BMP4, SOX9 and GREM1. During branchial arch development, acts to mediate HOXA2 control over the insulin-like growth factor pathway. May also be involved in limb tendon and ligament development (By similarity). Plays a role in cell proliferation and migration","subcellular_location":"Nucleus","url":"https://www.uniprot.org/uniprotkb/Q9NPC8/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/SIX2","classification":"Not Classified","n_dependent_lines":0,"n_total_lines":1208,"dependency_fraction":0.0},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/SIX2","total_profiled":1310},"omim":[{"mim_id":"618744","title":"DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 83; DEE83","url":"https://www.omim.org/entry/618744"},{"mim_id":"607375","title":"DOT1-LIKE; DOT1L","url":"https://www.omim.org/entry/607375"},{"mim_id":"606342","title":"SIX HOMEOBOX 4; SIX4","url":"https://www.omim.org/entry/606342"},{"mim_id":"606326","title":"SIX HOMEOBOX 6; SIX6","url":"https://www.omim.org/entry/606326"},{"mim_id":"604994","title":"SIX HOMEOBOX 2; SIX2","url":"https://www.omim.org/entry/604994"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Supported","locations":[{"location":"Nucleoplasm","reliability":"Supported"},{"location":"Nuclear membrane","reliability":"Additional"}],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in many","driving_tissues":[{"tissue":"salivary gland","ntpm":19.9},{"tissue":"skeletal muscle","ntpm":32.0}],"url":"https://www.proteinatlas.org/search/SIX2"},"hgnc":{"alias_symbol":[],"prev_symbol":[]},"alphafold":{"accession":"Q9NPC8","domains":[{"cath_id":"1.10.10.60","chopping":"132-190","consensus_level":"high","plddt":95.0785,"start":132,"end":190},{"cath_id":"1.25.40","chopping":"10-113","consensus_level":"high","plddt":95.0283,"start":10,"end":113}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9NPC8","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q9NPC8-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q9NPC8-F1-predicted_aligned_error_v6.png","plddt_mean":74.12},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=SIX2","jax_strain_url":"https://www.jax.org/strain/search?query=SIX2"},"sequence":{"accession":"Q9NPC8","fasta_url":"https://rest.uniprot.org/uniprotkb/Q9NPC8.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q9NPC8/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9NPC8"}},"corpus_meta":[{"pmid":"18682239","id":"PMC_18682239","title":"Six2 defines and regulates a multipotent self-renewing nephron progenitor population throughout mammalian kidney development.","date":"2008","source":"Cell stem cell","url":"https://pubmed.ncbi.nlm.nih.gov/18682239","citation_count":757,"is_preprint":false},{"pmid":"17036046","id":"PMC_17036046","title":"Six2 is required for suppression of nephrogenesis and progenitor renewal in the developing kidney.","date":"2006","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/17036046","citation_count":377,"is_preprint":false},{"pmid":"22902740","id":"PMC_22902740","title":"Six2 and Wnt regulate self-renewal and commitment of nephron progenitors through shared gene regulatory networks.","date":"2012","source":"Developmental cell","url":"https://pubmed.ncbi.nlm.nih.gov/22902740","citation_count":211,"is_preprint":false},{"pmid":"25458011","id":"PMC_25458011","title":"Eya1 interacts with Six2 and Myc to regulate expansion of the nephron progenitor pool during nephrogenesis.","date":"2014","source":"Developmental cell","url":"https://pubmed.ncbi.nlm.nih.gov/25458011","citation_count":97,"is_preprint":false},{"pmid":"15327782","id":"PMC_15327782","title":"The transcription factor Six2 activates expression of the Gdnf gene as well as its own promoter.","date":"2004","source":"Mechanisms of development","url":"https://pubmed.ncbi.nlm.nih.gov/15327782","citation_count":87,"is_preprint":false},{"pmid":"24598167","id":"PMC_24598167","title":"Osr1 acts downstream of and interacts synergistically with Six2 to maintain nephron progenitor cells during kidney organogenesis.","date":"2014","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/24598167","citation_count":69,"is_preprint":false},{"pmid":"30832689","id":"PMC_30832689","title":"Transcriptional factor six2 promotes the competitive endogenous RNA network between CYP4Z1 and pseudogene CYP4Z2P responsible for maintaining the stemness of breast cancer cells.","date":"2019","source":"Journal of hematology & oncology","url":"https://pubmed.ncbi.nlm.nih.gov/30832689","citation_count":67,"is_preprint":false},{"pmid":"27633993","id":"PMC_27633993","title":"Notch signaling promotes nephrogenesis by downregulating Six2.","date":"2016","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/27633993","citation_count":56,"is_preprint":false},{"pmid":"25348955","id":"PMC_25348955","title":"Homeoprotein Six2 promotes breast cancer metastasis via transcriptional and epigenetic control of E-cadherin expression.","date":"2014","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/25348955","citation_count":55,"is_preprint":false},{"pmid":"31962380","id":"PMC_31962380","title":"Circular RNA 0007255 regulates the progression of breast cancer through miR-335-5p/SIX2 axis.","date":"2020","source":"Thoracic cancer","url":"https://pubmed.ncbi.nlm.nih.gov/31962380","citation_count":48,"is_preprint":false},{"pmid":"28122228","id":"PMC_28122228","title":"Temporally Distinct Six2-Positive Second Heart Field Progenitors Regulate Mammalian Heart Development and Disease.","date":"2017","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/28122228","citation_count":44,"is_preprint":false},{"pmid":"28435452","id":"PMC_28435452","title":"The YAP1/SIX2 axis is required for DDX3-mediated tumor aggressiveness and cetuximab resistance in KRAS-wild-type colorectal cancer.","date":"2017","source":"Theranostics","url":"https://pubmed.ncbi.nlm.nih.gov/28435452","citation_count":43,"is_preprint":false},{"pmid":"18321982","id":"PMC_18321982","title":"Six2 functions redundantly immediately downstream of Hoxa2.","date":"2008","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/18321982","citation_count":41,"is_preprint":false},{"pmid":"30606720","id":"PMC_30606720","title":"SIX2 Mediates Late-Stage Metastasis via Direct Regulation of SOX2 and Induction of a Cancer Stem Cell Program.","date":"2019","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/30606720","citation_count":40,"is_preprint":false},{"pmid":"31959818","id":"PMC_31959818","title":"The FGF, TGFβ and WNT axis Modulate Self-renewal of Human SIX2+ Urine Derived Renal Progenitor Cells.","date":"2020","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/31959818","citation_count":40,"is_preprint":false},{"pmid":"30905259","id":"PMC_30905259","title":"Crucial and Overlapping Roles of Six1 and Six2 in Craniofacial Development.","date":"2019","source":"Journal of dental research","url":"https://pubmed.ncbi.nlm.nih.gov/30905259","citation_count":39,"is_preprint":false},{"pmid":"22703800","id":"PMC_22703800","title":"SIX2 and CITED1, markers of nephronic progenitor self-renewal, remain active in primitive elements of Wilms' tumor.","date":"2012","source":"Journal of pediatric surgery","url":"https://pubmed.ncbi.nlm.nih.gov/22703800","citation_count":37,"is_preprint":false},{"pmid":"32460030","id":"PMC_32460030","title":"SIX2 Regulates Human β Cell Differentiation from Stem Cells and Functional Maturation In Vitro.","date":"2020","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/32460030","citation_count":36,"is_preprint":false},{"pmid":"20515681","id":"PMC_20515681","title":"Inactivation of Six2 in mouse identifies a novel genetic mechanism controlling development and growth of the cranial base.","date":"2010","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/20515681","citation_count":36,"is_preprint":false},{"pmid":"30850438","id":"PMC_30850438","title":"DNMT1 in Six2 Progenitor Cells Is Essential for Transposable Element Silencing and Kidney Development.","date":"2019","source":"Journal of the American Society of Nephrology : JASN","url":"https://pubmed.ncbi.nlm.nih.gov/30850438","citation_count":35,"is_preprint":false},{"pmid":"33446570","id":"PMC_33446570","title":"SIX2 and SIX3 coordinately regulate functional maturity and fate of human pancreatic β cells.","date":"2021","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/33446570","citation_count":34,"is_preprint":false},{"pmid":"26321142","id":"PMC_26321142","title":"Preferential Propagation of Competent SIX2+ Nephronic Progenitors by LIF/ROCKi Treatment of the Metanephric Mesenchyme.","date":"2015","source":"Stem cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/26321142","citation_count":33,"is_preprint":false},{"pmid":"23499659","id":"PMC_23499659","title":"Wnt and BMP signaling cooperate with Hox in the control of Six2 expression in limb tendon precursor.","date":"2013","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/23499659","citation_count":33,"is_preprint":false},{"pmid":"18570229","id":"PMC_18570229","title":"Misexpression of Six2 is associated with heritable frontonasal dysplasia and renal hypoplasia in 3H1 Br mice.","date":"2008","source":"Developmental dynamics : an official publication of the American Association of Anatomists","url":"https://pubmed.ncbi.nlm.nih.gov/18570229","citation_count":33,"is_preprint":false},{"pmid":"19716816","id":"PMC_19716816","title":"Non-homeodomain regions of Hox proteins mediate activation versus repression of Six2 via a single enhancer site in vivo.","date":"2009","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/19716816","citation_count":30,"is_preprint":false},{"pmid":"29217079","id":"PMC_29217079","title":"Haploinsufficiency for the Six2 gene increases nephron progenitor proliferation promoting branching and nephron number.","date":"2017","source":"Kidney international","url":"https://pubmed.ncbi.nlm.nih.gov/29217079","citation_count":29,"is_preprint":false},{"pmid":"22912798","id":"PMC_22912798","title":"Conditional expression of Wnt9b in Six2-positive cells disrupts stomach and kidney function.","date":"2012","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/22912798","citation_count":29,"is_preprint":false},{"pmid":"10773454","id":"PMC_10773454","title":"Structure, mapping and expression of the human gene encoding the homeodomain protein, SIX2.","date":"2000","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/10773454","citation_count":29,"is_preprint":false},{"pmid":"29170429","id":"PMC_29170429","title":"Genome-wide meta-analysis in Japanese populations identifies novel variants at the TMC6-TMC8 and SIX3-SIX2 loci associated with HbA1c.","date":"2017","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/29170429","citation_count":28,"is_preprint":false},{"pmid":"19193724","id":"PMC_19193724","title":"Deficiency in Six2 during prenatal development is associated with reduced nephron number, chronic renal failure, and hypertension in Br/+ adult mice.","date":"2009","source":"American journal of physiology. Renal physiology","url":"https://pubmed.ncbi.nlm.nih.gov/19193724","citation_count":27,"is_preprint":false},{"pmid":"27212161","id":"PMC_27212161","title":"MicroRNA-185 inhibits cell proliferation and epithelial-mesenchymal transition in hepatocellular carcinoma by targeting Six2.","date":"2016","source":"European review for medical and pharmacological sciences","url":"https://pubmed.ncbi.nlm.nih.gov/27212161","citation_count":25,"is_preprint":false},{"pmid":"26581443","id":"PMC_26581443","title":"A new frontonasal dysplasia syndrome associated with deletion of the SIX2 gene.","date":"2015","source":"American journal of medical genetics. Part A","url":"https://pubmed.ncbi.nlm.nih.gov/26581443","citation_count":25,"is_preprint":false},{"pmid":"25500091","id":"PMC_25500091","title":"SIX2 Effects on Wilms Tumor Biology.","date":"2014","source":"Translational oncology","url":"https://pubmed.ncbi.nlm.nih.gov/25500091","citation_count":24,"is_preprint":false},{"pmid":"22995329","id":"PMC_22995329","title":"The pluripotent renal stem cell regulator SIX2 is activated in renal neoplasms and influences cellular proliferation and migration.","date":"2012","source":"Human pathology","url":"https://pubmed.ncbi.nlm.nih.gov/22995329","citation_count":24,"is_preprint":false},{"pmid":"19660448","id":"PMC_19660448","title":"Six2 activity is required for the formation of the mammalian pyloric sphincter.","date":"2009","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/19660448","citation_count":24,"is_preprint":false},{"pmid":"24055707","id":"PMC_24055707","title":"MiR-181b targets Six2 and inhibits the proliferation of metanephric mesenchymal cells in vitro.","date":"2013","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/24055707","citation_count":22,"is_preprint":false},{"pmid":"27148690","id":"PMC_27148690","title":"Transcription factor Six2 mediates the protection of GDNF on 6-OHDA lesioned dopaminergic neurons by regulating Smurf1 expression.","date":"2016","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/27148690","citation_count":22,"is_preprint":false},{"pmid":"29035842","id":"PMC_29035842","title":"Derivation and characterization of integration-free iPSC line ISRM-UM51 derived from SIX2-positive renal cells isolated from urine of an African male expressing the CYP2D6 *4/*17 variant which confers intermediate drug metabolizing activity.","date":"2017","source":"Stem cell research","url":"https://pubmed.ncbi.nlm.nih.gov/29035842","citation_count":22,"is_preprint":false},{"pmid":"31012173","id":"PMC_31012173","title":"Six2 promotes non-small cell lung cancer cell stemness via transcriptionally and epigenetically regulating E-cadherin.","date":"2019","source":"Cell proliferation","url":"https://pubmed.ncbi.nlm.nih.gov/31012173","citation_count":22,"is_preprint":false},{"pmid":"20542577","id":"PMC_20542577","title":"Mutational analysis of HOXA2 and SIX2 in a Bronx population with isolated microtia.","date":"2010","source":"International journal of pediatric otorhinolaryngology","url":"https://pubmed.ncbi.nlm.nih.gov/20542577","citation_count":21,"is_preprint":false},{"pmid":"27509493","id":"PMC_27509493","title":"Zeb1 Is a Potential Regulator of Six2 in the Proliferation, Apoptosis and Migration of Metanephric Mesenchyme Cells.","date":"2016","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/27509493","citation_count":21,"is_preprint":false},{"pmid":"29218017","id":"PMC_29218017","title":"Six2 Plays an Intrinsic Role in Regulating Proliferation of Mesenchymal Cells in the Developing Palate.","date":"2017","source":"Frontiers in physiology","url":"https://pubmed.ncbi.nlm.nih.gov/29218017","citation_count":18,"is_preprint":false},{"pmid":"27383657","id":"PMC_27383657","title":"SIX2 haploinsufficiency causes conductive hearing loss with ptosis in humans.","date":"2016","source":"Journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/27383657","citation_count":15,"is_preprint":false},{"pmid":"31765609","id":"PMC_31765609","title":"Six2 regulates Pax9 expression, palatogenesis and craniofacial bone formation.","date":"2019","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/31765609","citation_count":13,"is_preprint":false},{"pmid":"38554106","id":"PMC_38554106","title":"SIX2 promotes cell plasticity via Wnt/β-catenin signalling in androgen receptor independent prostate cancer.","date":"2024","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/38554106","citation_count":13,"is_preprint":false},{"pmid":"35913414","id":"PMC_35913414","title":"De novo SIX2 activation in human kidneys treated with neonatal kidney stem/progenitor cells.","date":"2022","source":"American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons","url":"https://pubmed.ncbi.nlm.nih.gov/35913414","citation_count":13,"is_preprint":false},{"pmid":"34716243","id":"PMC_34716243","title":"Chromatin Remodelers Interact with Eya1 and Six2 to Target Enhancers to Control Nephron Progenitor Cell Maintenance.","date":"2021","source":"Journal of the American Society of Nephrology : JASN","url":"https://pubmed.ncbi.nlm.nih.gov/34716243","citation_count":13,"is_preprint":false},{"pmid":"25187057","id":"PMC_25187057","title":"miR181c promotes apoptosis and suppresses proliferation of metanephric mesenchyme cells by targeting Six2 in vitro.","date":"2014","source":"Cell biochemistry and function","url":"https://pubmed.ncbi.nlm.nih.gov/25187057","citation_count":13,"is_preprint":false},{"pmid":"31090452","id":"PMC_31090452","title":"PPARG Negatively Modulates Six2 in Tumor Formation of Clear Cell Renal Cell Carcinoma.","date":"2019","source":"DNA and cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/31090452","citation_count":12,"is_preprint":false},{"pmid":"29444177","id":"PMC_29444177","title":"Kidney-differentiated cells derived from Lowe Syndrome patient's iPSCs show ciliogenesis defects and Six2 retention at the Golgi complex.","date":"2018","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/29444177","citation_count":12,"is_preprint":false},{"pmid":"26009236","id":"PMC_26009236","title":"Identification of distal enhancers for Six2 expression in pronephros.","date":"2015","source":"The International journal of developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/26009236","citation_count":11,"is_preprint":false},{"pmid":"27144443","id":"PMC_27144443","title":"Postembryonic Nephrogenesis and Persistence of Six2-Expressing Nephron Progenitor Cells in the Reptilian Kidney.","date":"2016","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/27144443","citation_count":11,"is_preprint":false},{"pmid":"24573885","id":"PMC_24573885","title":"Down-regulated Six2 by knockdown of neurofibromin results in apoptosis of metanephric mesenchyme cells in vitro.","date":"2014","source":"Molecular and cellular biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/24573885","citation_count":9,"is_preprint":false},{"pmid":"27618015","id":"PMC_27618015","title":"Six2 Is a Coordinator of LiCl-Induced Cell Proliferation and Apoptosis.","date":"2016","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/27618015","citation_count":8,"is_preprint":false},{"pmid":"35178390","id":"PMC_35178390","title":"Six1 and Six2 of the Sine Oculis Homeobox Subfamily are Not Functionally Interchangeable in Mouse Nephron Formation.","date":"2022","source":"Frontiers in cell and developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/35178390","citation_count":8,"is_preprint":false},{"pmid":"29315086","id":"PMC_29315086","title":"SIX2 gene haploinsufficiency leads to a recognizable phenotype with ptosis, frontonasal dysplasia, and conductive hearing loss.","date":"2018","source":"Clinical dysmorphology","url":"https://pubmed.ncbi.nlm.nih.gov/29315086","citation_count":8,"is_preprint":false},{"pmid":"36522157","id":"PMC_36522157","title":"Tet2- and Tet3- Mediated Cytosine Hydroxymethylation in Six2 Progenitor Cells in Mice Is Critical for Nephron Progenitor Differentiation and Nephron Endowment.","date":"2022","source":"Journal of the American Society of Nephrology : JASN","url":"https://pubmed.ncbi.nlm.nih.gov/36522157","citation_count":7,"is_preprint":false},{"pmid":"38447671","id":"PMC_38447671","title":"Reduced Nephron Endowment in Six2-TGCtg Mice Is Due to Six3 Misexpression by Aberrant Enhancer-Promoter Interactions in the Transgene.","date":"2024","source":"Journal of the American Society of Nephrology : JASN","url":"https://pubmed.ncbi.nlm.nih.gov/38447671","citation_count":7,"is_preprint":false},{"pmid":"31720997","id":"PMC_31720997","title":"MES23.5 DA Immortalized Neuroblastoma Cells Self-protect Against Early Injury by Overexpressing Glial Cell-derived Neurotrophic Factor via Akt1/Eya1/Six2 Signaling.","date":"2019","source":"Journal of molecular neuroscience : MN","url":"https://pubmed.ncbi.nlm.nih.gov/31720997","citation_count":7,"is_preprint":false},{"pmid":"39556430","id":"PMC_39556430","title":"Six2 regulates the malignant progression and 5-FU resistance of hepatocellular carcinoma through the PI3K/AKT/mTOR pathway and DNMT1/E-cadherin methylation mechanism.","date":"2024","source":"Neoplasma","url":"https://pubmed.ncbi.nlm.nih.gov/39556430","citation_count":6,"is_preprint":false},{"pmid":"38688414","id":"PMC_38688414","title":"Microglial SIX2 suppresses lipopolysaccharide (LPS)-induced neuroinflammation by up-regulating FXYD2 expression.","date":"2024","source":"Brain research bulletin","url":"https://pubmed.ncbi.nlm.nih.gov/38688414","citation_count":4,"is_preprint":false},{"pmid":"37461228","id":"PMC_37461228","title":"NIK-mediated reactivation of SIX2 enhanced the CSC-like traits of hepatocellular carcinoma cells through suppressing ubiquitin-proteasome system.","date":"2023","source":"Environmental toxicology","url":"https://pubmed.ncbi.nlm.nih.gov/37461228","citation_count":4,"is_preprint":false},{"pmid":"34233203","id":"PMC_34233203","title":"Smarcd1 antagonizes the apoptosis of injured MES23.5 DA cells by enhancing the effect of Six2 on GDNF expression.","date":"2021","source":"Neuroscience letters","url":"https://pubmed.ncbi.nlm.nih.gov/34233203","citation_count":4,"is_preprint":false},{"pmid":"39256760","id":"PMC_39256760","title":"The SIX2/PFN2 feedback loop promotes the stemness of gastric cancer cells.","date":"2024","source":"Journal of translational medicine","url":"https://pubmed.ncbi.nlm.nih.gov/39256760","citation_count":4,"is_preprint":false},{"pmid":"32277572","id":"PMC_32277572","title":"Generation and characterization of Six2 conditional mice.","date":"2020","source":"Genesis (New York, N.Y. : 2000)","url":"https://pubmed.ncbi.nlm.nih.gov/32277572","citation_count":3,"is_preprint":false},{"pmid":"31420918","id":"PMC_31420918","title":"Transcription factor Six2 induces a stem cell-like phenotype in renal cell carcinoma cells.","date":"2019","source":"FEBS open bio","url":"https://pubmed.ncbi.nlm.nih.gov/31420918","citation_count":3,"is_preprint":false},{"pmid":"28842839","id":"PMC_28842839","title":"Six2 is involved in GATA1-mediated cell apoptosis in mouse embryonic kidney-derived cell lines.","date":"2017","source":"In vitro cellular & developmental biology. Animal","url":"https://pubmed.ncbi.nlm.nih.gov/28842839","citation_count":3,"is_preprint":false},{"pmid":"37308406","id":"PMC_37308406","title":"[Effects of transcription factor SIX2 gene on the proliferation of bovine skeletal muscle satellite cells].","date":"2022","source":"Zhongguo ying yong sheng li xue za zhi = Zhongguo yingyong shenglixue zazhi = Chinese journal of applied physiology","url":"https://pubmed.ncbi.nlm.nih.gov/37308406","citation_count":3,"is_preprint":false},{"pmid":"28420207","id":"PMC_28420207","title":"TβRII Regulates the Proliferation of Metanephric Mesenchyme Cells through Six2 In Vitro.","date":"2017","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/28420207","citation_count":3,"is_preprint":false},{"pmid":"31191670","id":"PMC_31191670","title":"Constructing an Isogenic 3D Human Nephrogenic Progenitor Cell Model Composed of Endothelial, Mesenchymal, and SIX2-Positive Renal Progenitor Cells.","date":"2019","source":"Stem cells international","url":"https://pubmed.ncbi.nlm.nih.gov/31191670","citation_count":3,"is_preprint":false},{"pmid":"30219227","id":"PMC_30219227","title":"Gulo regulates the proliferation, apoptosis and mesenchymal-to-epithelial transformation of metanephric mesenchyme cells via inhibiting Six2.","date":"2018","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/30219227","citation_count":2,"is_preprint":false},{"pmid":"21653879","id":"PMC_21653879","title":"Osmoregulatory defect in adult mice associated with deficient prenatal expression of six2.","date":"2011","source":"American journal of physiology. Regulatory, integrative and comparative physiology","url":"https://pubmed.ncbi.nlm.nih.gov/21653879","citation_count":2,"is_preprint":false},{"pmid":"24124738","id":"PMC_24124738","title":"[Expression and promoter methylation of SIX2 gene in peripheral blood of pediatric patients with nephroblastoma].","date":"2013","source":"Zhonghua yi xue za zhi","url":"https://pubmed.ncbi.nlm.nih.gov/24124738","citation_count":2,"is_preprint":false},{"pmid":"40954199","id":"PMC_40954199","title":"TRIM21-mediated ubiquitination of SIX2 attenuates breast cancer stemness via LGSN suppression.","date":"2025","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/40954199","citation_count":1,"is_preprint":false},{"pmid":"37873415","id":"PMC_37873415","title":"Reduced nephron endowment in the common Six2-TGC  mouse line is due to Six3 misexpression by aberrant enhancer-promoter interactions in the transgene.","date":"2023","source":"bioRxiv : the preprint server for biology","url":"https://pubmed.ncbi.nlm.nih.gov/37873415","citation_count":1,"is_preprint":false},{"pmid":"41168982","id":"PMC_41168982","title":"Human Urine-Derived SIX2-Positive Renal Progenitor Cells Partially Improve Kidney Fibrosis by Paracrine Signaling.","date":"2025","source":"Stem cells and development","url":"https://pubmed.ncbi.nlm.nih.gov/41168982","citation_count":1,"is_preprint":false},{"pmid":"34109599","id":"PMC_34109599","title":"MicroRNA-185 inhibits cell proliferation and epithelial-mesenchymal transition in hepatocellular carcinoma by targeting Six2.","date":"2021","source":"European review for medical and pharmacological sciences","url":"https://pubmed.ncbi.nlm.nih.gov/34109599","citation_count":1,"is_preprint":false},{"pmid":"31651345","id":"PMC_31651345","title":"Correction to: Transcriptional factor six2 promotes the competitive endogenous RNA network between CYP4Z1 and pseudogene CYP4Z2P responsible for maintaining the stemness of breast cancer cells.","date":"2019","source":"Journal of hematology & oncology","url":"https://pubmed.ncbi.nlm.nih.gov/31651345","citation_count":1,"is_preprint":false},{"pmid":"41225540","id":"PMC_41225540","title":"Modelling APOL1-mediated kidney inflammation and fibrosis using a partially reprogrammed urine-derived SIX2-positive renal progenitor cell line.","date":"2025","source":"Stem cell research & therapy","url":"https://pubmed.ncbi.nlm.nih.gov/41225540","citation_count":0,"is_preprint":false},{"pmid":"41112069","id":"PMC_41112069","title":"OSR1 and SIX2 drive divergent transcriptional programs in human kidney cells: implications for regeneration and tumorigenesis.","date":"2025","source":"Frontiers in bioengineering and biotechnology","url":"https://pubmed.ncbi.nlm.nih.gov/41112069","citation_count":0,"is_preprint":false},{"pmid":"40523929","id":"PMC_40523929","title":"Targeting SIX2 as a novel sensitization strategy of sorafenib treatment on advanced hepatocellular carcinoma through modulating METTL9-SLC7A11 axis.","date":"2025","source":"NPJ precision oncology","url":"https://pubmed.ncbi.nlm.nih.gov/40523929","citation_count":0,"is_preprint":false},{"pmid":"41700504","id":"PMC_41700504","title":"SIX2-Mediated Microglial M2 Polarization and Exosomal miR-3470b Delivery Protect Dopaminergic Neurons in Parkinson's Disease.","date":"2026","source":"CNS neuroscience & therapeutics","url":"https://pubmed.ncbi.nlm.nih.gov/41700504","citation_count":0,"is_preprint":false},{"pmid":"38804816","id":"PMC_38804816","title":"RETRACTION: Six2 Promotes Non-Small Cell Lung Cancer Cell Stemness Via Transcriptionally and Epigenetically Regulating E-Cadherin.","date":"2024","source":"Cell proliferation","url":"https://pubmed.ncbi.nlm.nih.gov/38804816","citation_count":0,"is_preprint":false},{"pmid":"41991886","id":"PMC_41991886","title":"EYA4 promotes cellular senescence by enhancing P21 transcription through interaction with SIX2.","date":"2026","source":"Advanced biotechnology","url":"https://pubmed.ncbi.nlm.nih.gov/41991886","citation_count":0,"is_preprint":false},{"pmid":null,"id":"bio_10.1101_2025.07.28.667124","title":"Modelling APOL1-mediated kidney inflammation and fibrosis using a partially reprogrammed urine derived SIX2-positive renal progenitor cell line","date":"2025-07-29","source":"bioRxiv","url":"https://doi.org/10.1101/2025.07.28.667124","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2025.07.02.662781","title":"Human Urine-derived SIX2-positive renal progenitor cells improve kidney injury in an IRI mouse model","date":"2025-07-03","source":"bioRxiv","url":"https://doi.org/10.1101/2025.07.02.662781","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2025.04.04.647241","title":"A Tonotopic Regulatory Axis Governing Isoform-Specific MYO7A Expression in Cochlear Hair Cells","date":"2025-04-05","source":"bioRxiv","url":"https://doi.org/10.1101/2025.04.04.647241","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2025.02.25.640014","title":"Lysine-specific demethylase 1a is obligatory for gene regulation during kidney development","date":"2025-02-26","source":"bioRxiv","url":"https://doi.org/10.1101/2025.02.25.640014","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2025.02.07.637033","title":"Dimethyl sulfoxide primes induced pluripotent stem cells for more efficient nephron progenitor and kidney organoid differentiation","date":"2025-02-08","source":"bioRxiv","url":"https://doi.org/10.1101/2025.02.07.637033","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2024.05.21.595131","title":"Developmental regulators drive DUX4 expression in facioscapulohumeral muscular dystrophy","date":"2024-05-21","source":"bioRxiv","url":"https://doi.org/10.1101/2024.05.21.595131","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2024.05.17.594179","title":"Select DYRK1A Inhibitors Enhance Both Proliferation and Differentiation in Human Pancreatic Beta Cells","date":"2024-05-17","source":"bioRxiv","url":"https://doi.org/10.1101/2024.05.17.594179","citation_count":0,"is_preprint":true}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":45532,"output_tokens":7456,"usd":0.124218},"stage2":{"model":"claude-opus-4-6","input_tokens":11258,"output_tokens":4441,"usd":0.250972},"total_usd":0.37519,"stage1_batch_id":"msgbatch_011rkcQdVV1RaFq9XhcG6df6","stage2_batch_id":"msgbatch_01RzgrJafdF4EWHhj5mNi6dh","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2008,\n      \"finding\": \"Six2-expressing cap mesenchyme cells represent a multipotent nephron progenitor population that self-renews throughout kidney development; Six2 functions cell-autonomously to maintain progenitor status, as cap mesenchyme cells lacking Six2 activity contribute to ectopic nephron tubules via a Wnt9b-dependent inductive signal.\",\n      \"method\": \"Genetic lineage tracing (Six2-Cre), clonal analysis, conditional knockout, organ culture\",\n      \"journal\": \"Cell stem cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal genetic methods (lineage tracing, clonal analysis, conditional KO) with clear cellular phenotype; highly cited foundational study\",\n      \"pmids\": [\"18682239\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"Six2 is required to maintain metanephric mesenchyme progenitor cells in an undifferentiated state by opposing Wnt inductive signals from the ureteric bud; functional inactivation of Six2 results in premature and ectopic epithelial differentiation and depletion of the progenitor pool, causing renal hypoplasia; gain of Six2 function prevents epithelial differentiation in organ culture.\",\n      \"method\": \"Loss-of-function mouse genetics, gain-of-function organ culture assay\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal gain/loss-of-function with defined cellular phenotype; replicated by multiple labs\",\n      \"pmids\": [\"17036046\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"Six2 and β-catenin co-occupy shared cis-regulatory modules at Wnt4 and Fgf8 loci in nephron progenitors; Six2 and Lef/Tcf factors form a regulatory complex that promotes progenitor maintenance, while entry of β-catenin into this complex promotes nephrogenesis; Six2-dependent self-renewal and canonical Wnt/β-catenin-directed commitment operate through shared gene regulatory networks.\",\n      \"method\": \"Chromatin immunoprecipitation (ChIP), transcriptional profiling, in vitro and in vivo co-occupancy analysis, Lef/Tcf binding site mutagenesis\",\n      \"journal\": \"Developmental cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — ChIP with functional validation and mutagenesis, strong mechanistic resolution\",\n      \"pmids\": [\"22902740\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Eya1 interacts with Six2 and Myc to control self-renewing nephron progenitor cell activity; Six2 mediates translocation of Eya1 to the nucleus, where Eya1 uses its threonine phosphatase activity to control Myc phosphorylation/dephosphorylation in progenitor cells.\",\n      \"method\": \"Co-immunoprecipitation, conditional knockout, cell fate tracing, nuclear translocation assay, phosphatase activity assay\",\n      \"journal\": \"Developmental cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — Co-IP, enzymatic activity assay, and in vivo conditional KO with defined molecular and cellular phenotype\",\n      \"pmids\": [\"25458011\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"Six2 activates expression of the Gdnf gene through two binding sites in the Gdnf promoter that resemble homeobox consensus sequences; Six2 possesses a transcriptional activation domain in its C-terminus and nuclear localization determinants in its Six domain; Six2 also binds and activates its own 930 bp promoter fragment.\",\n      \"method\": \"Promoter-reporter assay, binding site identification, transgenic LacZ reporter mice, protein domain analysis\",\n      \"journal\": \"Mechanisms of development\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — promoter binding and activation assays with transgenic validation, single lab\",\n      \"pmids\": [\"15327782\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Six2 is required to maintain Osr1 expression in the undifferentiated cap mesenchyme; Osr1 and Six2 act synergistically to prevent premature differentiation; Osr1 (but not Six2) enhances TCF interaction with Groucho family co-repressors, stabilizing TCF-Groucho repressor complexes to antagonize Wnt-directed nephrogenic differentiation.\",\n      \"method\": \"Conditional knockout, protein interaction co-IP, Wnt4 enhancer reporter assay in vivo, epistasis\",\n      \"journal\": \"Development (Cambridge, England)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods (KO, Co-IP, reporter assay in vivo) with defined pathway placement\",\n      \"pmids\": [\"24598167\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Notch signaling promotes differentiation of nephron progenitors by downregulating Six2; Notch signaling is necessary and sufficient for Six2 downregulation; nephron progenitors lacking Notch signaling fail to differentiate into any nephron segments.\",\n      \"method\": \"Conditional gain- and loss-of-function mouse genetics, immunofluorescence\",\n      \"journal\": \"Development (Cambridge, England)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal gain/loss-of-function with clear epistatic relationship and cellular phenotype\",\n      \"pmids\": [\"27633993\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Six2 promotes breast cancer metastasis by repressing E-cadherin expression through transcriptional upregulation of Zeb2 (partly via a microRNA-mediated mechanism) and by stimulating promoter methylation of the Cdh1 gene; E-cadherin downregulation is required for Six2-enhanced soft agar growth and in vivo metastasis.\",\n      \"method\": \"Overexpression/knockdown, methylation assay, in vivo metastasis model, epistasis rescue experiment\",\n      \"journal\": \"Cancer research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — multiple functional assays with epigenetic mechanistic follow-up, single lab\",\n      \"pmids\": [\"25348955\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Six2 directly binds the Sox2 Srr2 enhancer, promoting Sox2 expression and downstream Nanog expression, thereby establishing a cancer stem cell program that enables metastatic colonization in triple-negative breast cancer models.\",\n      \"method\": \"ChIP, overexpression/knockdown, enhancer reporter assay, in vivo metastasis model\",\n      \"journal\": \"Cancer research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — ChIP with functional validation in multiple TNBC models, single lab\",\n      \"pmids\": [\"30606720\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"Six2 is a direct downstream target of Hoxa2 in vivo; ectopic expression of Six2 in the absence of Hoxa2 contributes to the Hoxa2 mutant phenotype; Six2 acts redundantly downstream of Hoxa2 and mediates Hoxa2 control over the insulin-like growth factor pathway during branchial arch development.\",\n      \"method\": \"Genetic epistasis, in vivo loss-of-function, ectopic expression\",\n      \"journal\": \"Development (Cambridge, England)\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — genetic epistasis with in vivo functional validation, single lab\",\n      \"pmids\": [\"18321982\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"A single enhancer upstream of the Six2 coding sequence is responsible for both activation by Hox11 proteins in the developing kidney and repression by Hoxa2 in branchial arch and facial mesenchyme; differential activity is conferred by protein domains N- and C-terminal to the homeodomain, not by homeodomain differences; DNA-binding activity is required for both activation and repression.\",\n      \"method\": \"In vivo enhancer analysis, domain-swap mutagenesis, transgenic reporter mice\",\n      \"journal\": \"Developmental biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — in vivo enhancer dissection with mutagenesis, single lab\",\n      \"pmids\": [\"19716816\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"LIF activates STAT signaling, which binds a Stat consensus sequence in the Six2 proximal promoter to sustain SIX2 levels in metanephric mesenchyme progenitors; ROCKi attenuates LIF-induced differentiation activity of JNK; LIF/ROCKi combination upregulates Slug expression and activates YAP to maintain SIX2, PAX2, and SALL1.\",\n      \"method\": \"Promoter-reporter assay, ChIP (STAT binding), pathway inhibition, culture expansion model\",\n      \"journal\": \"Stem cell reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — STAT binding to Six2 promoter demonstrated by ChIP with functional rescue, single lab\",\n      \"pmids\": [\"26321142\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Six2 activity is required for formation of the pyloric sphincter by regulating a gene network including Bmp4, Bmpr1b, Nkx2.5, Sox9, and Gremlin in mammals.\",\n      \"method\": \"Loss-of-function mouse genetics, gene expression analysis\",\n      \"journal\": \"Developmental biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — KO with defined phenotypic readout and downstream target identification, single lab\",\n      \"pmids\": [\"19660448\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Six2 transcription factor mediates the protective effects of GDNF on damaged dopaminergic neurons by directly binding the CAGCTG promoter sequence of Smurf1 and regulating its expression, which in turn modulates p53 levels; the Akt1/Eya1/Six2 signaling cascade controls GDNF transcription in MES23.5 DA cells by direct Six2 binding to the GDNF promoter.\",\n      \"method\": \"ChIP-seq, ChIP-qPCR, knockdown/overexpression, in vivo 6-OHDA lesion model\",\n      \"journal\": \"Cell death & disease\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — ChIP-seq with functional validation in vivo, single lab\",\n      \"pmids\": [\"27148690\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"MES23.5 DA cells respond to early 6-OHDA injury by activating an Akt1/Eya1/Six2 signaling pathway; activated Akt1 phosphorylates Eya1, which then decreases Six2 phosphorylation; dephosphorylated Six2 promotes GDNF transcription by directly binding the GDNF promoter, conferring neuroprotection.\",\n      \"method\": \"ChIP-qPCR, phosphorylation assays, knockdown/overexpression, cell viability assays\",\n      \"journal\": \"Journal of molecular neuroscience : MN\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — ChIP-qPCR with phosphorylation cascade characterization, single lab\",\n      \"pmids\": [\"31720997\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"Eya1 and Six2 interact with the Brg1-based SWI/SNF chromatin-remodeling complex during kidney development; Brg1 occupies a distal enhancer of Eya1 driving nephron progenitor-specific expression; Brg1 enrichment to distal intronic enhancers of Pbx1 and a proximal promoter of Mycn requires Six2 activity, and these Brg1/Six2-bound enhancers govern nephron progenitor-specific expression.\",\n      \"method\": \"Co-immunoprecipitation (tagged knock-in), genome-wide ChIP, enhancer reporter assay in vivo, conditional knockout\",\n      \"journal\": \"Journal of the American Society of Nephrology : JASN\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — tagged knock-in CoIP with genome-wide ChIP and in vivo enhancer validation, multiple orthogonal methods\",\n      \"pmids\": [\"34716243\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"SIX2 knockdown in human pancreatic islets impairs glucose-stimulated insulin secretion, cytoplasmic calcium flux, and mitochondrial respiration; SIX2 directly regulates the expression of genes governing β-cell insulin processing, glucose sensing, and electrophysiology, as determined by chromatin accessibility studies.\",\n      \"method\": \"shRNA knockdown, ATAC-seq (chromatin accessibility), functional secretion assays, transcriptome profiling\",\n      \"journal\": \"Genes & development\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple functional assays with chromatin accessibility mapping, single lab\",\n      \"pmids\": [\"33446570\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"SIX2 regulates functional maturation of stem cell-derived β cells; knockout or knockdown of SIX2 drastically limits glucose-stimulated insulin secretion, cytoplasmic calcium flux, and mitochondrial respiration, and reduces expression of key β-cell functional genes.\",\n      \"method\": \"KD/KO in hESC-derived SC-β cells, static and dynamic insulin secretion assays, calcium imaging, Seahorse metabolic assay\",\n      \"journal\": \"Cell reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal functional readouts with KD/KO, single lab\",\n      \"pmids\": [\"32460030\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"Six2 marks a dynamic subset of second heart field progenitors whose descendants are successively allocated to regions of the heart from the right ventricle to the pulmonary trunk; global ablation of Six2+ progenitors results in right ventricular hypoplasia and pulmonary atresia; early-stage ablation of a small subset causes adult-onset cardiac hypertrophy; Six2 expression in cardiac progenitors depends partly on Shh signaling.\",\n      \"method\": \"Genetic lineage tracing, conditional cell ablation, Shh deletion epistasis\",\n      \"journal\": \"Cell reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — genetic lineage tracing and ablation with defined cardiac phenotypes, single lab\",\n      \"pmids\": [\"28122228\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"SIX2 expression in prostate cancer promotes a stem-like to epithelial cell state switch via the Wnt/β-catenin signaling pathway; SIX2 depletion in androgen-independent PC-3 cells reduces nuclear β-catenin and decreases cancer-related properties including proliferation, colony formation, and metastasis in vitro and in vivo.\",\n      \"method\": \"SIX2 knockdown, chromatin accessibility (ATAC-seq), in vitro and in vivo functional assays, nuclear β-catenin measurement\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — ATAC-seq with functional in vitro and in vivo validation, single lab\",\n      \"pmids\": [\"38554106\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Six2 directly binds the promoters of CYP4Z1 and CYP4Z2P to activate the ceRNA network between them, thereby activating the downstream PI3K/Akt and ERK1/2 pathways and maintaining breast cancer stemness.\",\n      \"method\": \"ChIP-seq, RNA-seq, lentiviral overexpression/knockdown, in vitro and in vivo stemness assays\",\n      \"journal\": \"Journal of hematology & oncology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — ChIP-seq with pathway validation, single lab\",\n      \"pmids\": [\"30832689\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"Six2 inactivation causes premature fusion of cranial base bones due to reduced chondrocyte proliferation and increased terminal differentiation; gain-of-function Six2 promotes cartilage development and growth, indicating Six2 controls general regulators of chondrocyte differentiation.\",\n      \"method\": \"Loss-of-function mouse genetics, gain-of-function experiments, histological analysis of chondrocyte differentiation\",\n      \"journal\": \"Developmental biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal loss/gain-of-function with defined cellular phenotype, single lab\",\n      \"pmids\": [\"20515681\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"In Lowe syndrome patient-derived kidney cells (OCRL1 mutant), Six2 is substantially retained in the Golgi complex with reduced nuclear localization; OCRL1 knockout in HK2 cells recapitulates both ciliogenesis defects and Six2 retention in the Golgi, indicating OCRL1-mediated phosphoinositide regulation controls Six2 nuclear trafficking.\",\n      \"method\": \"iPSC differentiation, OCRL1 KO, immunofluorescence subcellular localization, ciliogenesis assay\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — localization with functional consequence in disease-relevant model, replicated in two cell systems\",\n      \"pmids\": [\"29444177\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"TRIM21 acts as an E3 ubiquitin ligase that binds to SIX2 via its PRY-SPRY domain and catalyzes K48-type ubiquitination at lysine residues K82, K89, and K97, promoting SIX2 degradation via the ubiquitin-proteasome pathway; this modification attenuates breast cancer stemness and metastasis; SIX2 transcriptionally activates LGSN through direct binding to its promoter.\",\n      \"method\": \"Co-IP, ubiquitination assay, site-specific mutagenesis (K82/89/97 residues), proteasome inhibitor rescue, ChIP, gain/loss-of-function\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1-2 — biochemical ubiquitination assay with mutagenesis and functional validation, single lab\",\n      \"pmids\": [\"40954199\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"Six2 in Six2 heterozygotes paradoxically increases nephron progenitor proliferation (elevated EdU labeling, increased MYC protein and MYC target gene transcription) and final nephron number, demonstrating that Six2's role in progenitor proliferation versus self-renewal is separable by dosage.\",\n      \"method\": \"Quantitative morphometry, EdU labeling, Western blot, transcriptional profiling, genetic epistasis with Fgf20 KO\",\n      \"journal\": \"Kidney international\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple quantitative methods with epistasis, single lab\",\n      \"pmids\": [\"29217079\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"Six1 and Six2 have divergent biochemical properties: forced expression of Six1 fails to rescue Six2-deficient kidney phenotype; Six1 mediates Eya1 nuclear translocation and inhibits premature epithelialization but fails to rescue proliferation defects and cell death caused by Six2 knockout; genome-wide binding shows Six1 selectively occupies a small subset of Six2 target sites.\",\n      \"method\": \"Conditional rescue genetics, genome-wide ChIP, cell proliferation/death assays, nuclear translocation assay\",\n      \"journal\": \"Frontiers in cell and developmental biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — genome-wide binding comparison with genetic rescue experiment, single lab\",\n      \"pmids\": [\"35178390\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"Six2 transcriptionally activates DDIT4, leading to mTOR inhibition, autophagy induction, and a shift from M1 to M2 microglial polarization; M2-polarized microglia release exosomes enriched in miR-3470b that suppress GREM1 in dopaminergic neurons, potentiating TGF-β signaling and rescuing neuronal apoptosis.\",\n      \"method\": \"RNA-seq, ChIP-qPCR, miRNA sequencing, exosome isolation/transfer, in vitro and in vivo (MPTP mouse) functional assays\",\n      \"journal\": \"CNS neuroscience & therapeutics\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 — complex mechanism in single lab study, no independent replication\",\n      \"pmids\": [\"41700504\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"SIX2 directly regulates METTL9 expression (CUT&Tag); METTL9 binds SLC7A11 (Co-IP) to enhance its stability and reduce ferroptosis, thereby conferring sorafenib resistance in HCC cells; this SIX2-METTL9-SLC7A11 axis operates independently of the GPX4 pathway.\",\n      \"method\": \"CUT&Tag, Co-IP, overexpression/knockdown, ferroptosis assays, in vivo mouse tumor model\",\n      \"journal\": \"NPJ precision oncology\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 — single lab, indirect pathway with multiple steps, limited mechanistic validation of each step\",\n      \"pmids\": [\"40523929\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Six2 directly binds the Sox2 enhancer to promote Sox2 expression and RCC cell stemness, forming a Six2/Sox2 axis; overexpression of Sox2 rescues the inhibitory effects of Six2 knockdown on RCC stemness.\",\n      \"method\": \"ChIP, overexpression/knockdown rescue, spheroid formation assay\",\n      \"journal\": \"FEBS open bio\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 — single lab, ChIP without mutagenesis or independent replication\",\n      \"pmids\": [\"31420918\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"Six2 transcriptionally activates GDNF in dopaminergic cells and forms a transcription complex with Smarcd1 (a SWI/SNF complex member); Smarcd1 is recruited to the 2840-2933 bp region of the GDNF promoter via Six2; knockdown of Smarcd1 inhibits Six2-mediated GDNF expression and increases apoptosis of injured DA neurons.\",\n      \"method\": \"LC-ESI-ITMS/MS (interactome screen), Co-IP, ChIP, overexpression/knockdown, cell viability assay\",\n      \"journal\": \"Neuroscience letters\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 — Co-IP and ChIP from single lab with functional follow-up, no independent validation\",\n      \"pmids\": [\"34233203\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Zeb1 promotes Six2 promoter activity (luciferase assay) and Six2 expression in metanephric mesenchyme cells; Zeb1 and Six2 coregulate cell proliferation and apoptosis.\",\n      \"method\": \"Dual-luciferase assay, Western blot, RT-PCR, knockdown/overexpression, EdU and flow cytometry assays\",\n      \"journal\": \"International journal of molecular sciences\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 — single lab, single method (luciferase) for transcriptional regulation\",\n      \"pmids\": [\"27509493\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"TGFβ type II receptor (TβRII) promotes Six2 expression through Smad3-mediated transcriptional regulation; Smad3 transcriptionally targets Six2 (bioinformatics + luciferase assay); knockdown of TβRII reduces Six2 expression and proliferation, and overexpression of Six2 partially rescues the proliferation defect.\",\n      \"method\": \"Luciferase assay, RT-PCR, Western blot, EdU proliferation assay, knockdown rescue\",\n      \"journal\": \"International journal of molecular sciences\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 — single method for transcriptional link (luciferase), single lab, no ChIP validation\",\n      \"pmids\": [\"28420207\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2026,\n      \"finding\": \"EYA4 interacts with SIX2 to promote expression of p21 and accelerate cellular senescence in a p53-dependent manner; this effect is independent of EYA4 phosphatase activity.\",\n      \"method\": \"Co-IP, knockdown/overexpression, phosphatase-deficient mutant, promoter reporter assay, senescence assays\",\n      \"journal\": \"Advanced biotechnology\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 — Co-IP with functional follow-up, single lab, single study\",\n      \"pmids\": [\"41991886\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"SIX2 directly binds the promoter of SIX2/PFN2; SIX2 directly activates PFN2 expression, and PFN2 in turn promotes SIX2 mRNA stability by recruiting RNA-binding protein YBX-1, activating the downstream MAPK/JNK pathway to enhance gastric cancer cell stemness.\",\n      \"method\": \"ChIP, RNA stability assay, IP-MS, Co-IP, JNK pathway inhibition, gain/loss-of-function\",\n      \"journal\": \"Journal of translational medicine\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 — multiple methods but complex multi-step mechanism from single lab, no replication\",\n      \"pmids\": [\"39256760\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"SIX2 is a homeodomain transcription factor that cell-autonomously maintains multipotent nephron progenitor cells in an undifferentiated state by forming regulatory complexes with Lef/Tcf factors (and co-occupying target loci with β-catenin) to suppress Wnt-directed differentiation; it acts downstream of Hox genes and upstream of Eya1/Myc, directly activates target gene promoters (Gdnf, Smurf1, Sox2, Pax9, LGSN) through sequence-specific DNA binding, interacts with the Brg1-SWI/SNF chromatin-remodeling complex, and is subject to post-translational regulation including Eya1-mediated nuclear translocation, phosphorylation control, and TRIM21-mediated K48-ubiquitination leading to proteasomal degradation.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"SIX2 is a homeodomain transcription factor that maintains multipotent progenitor populations in an undifferentiated, self-renewing state, most extensively characterized in nephron progenitors of the developing kidney but also operative in cardiac, craniofacial, and pancreatic β-cell contexts. In nephron progenitors, SIX2 opposes Wnt9b/β-catenin–directed epithelial differentiation by co-occupying cis-regulatory modules at target loci (Wnt4, Fgf8) together with Lef/Tcf factors and by recruiting the Brg1-SWI/SNF chromatin-remodeling complex to progenitor-specific enhancers [PMID:22902740, PMID:34716243]. SIX2 possesses a C-terminal transcriptional activation domain and directly activates promoters of Gdnf, Smurf1, Sox2, and other targets through sequence-specific DNA binding, and its activity is controlled post-translationally by Eya1-mediated dephosphorylation facilitating nuclear translocation and by TRIM21-catalyzed K48-linked ubiquitination targeting it for proteasomal degradation [PMID:15327782, PMID:25458011, PMID:40954199]. In cancer contexts, SIX2 reactivates stem-cell programs—including Sox2, E-cadherin repression via Zeb2, and PI3K/Akt signaling—to promote metastasis and therapy resistance [PMID:25348955, PMID:30606720].\",\n  \"teleology\": [\n    {\n      \"year\": 2004,\n      \"claim\": \"Establishing that SIX2 is a sequence-specific transcriptional activator resolved the basic molecular activity of the protein: it binds homeodomain-like elements in the Gdnf promoter and its own promoter, and carries a C-terminal activation domain.\",\n      \"evidence\": \"Promoter-reporter assays, binding-site identification, and transgenic LacZ reporter mice\",\n      \"pmids\": [\"15327782\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No genome-wide binding map; target specificity versus other SIX family members unknown\", \"Activation domain boundaries not precisely mapped\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Demonstrating that Six2 loss causes premature epithelial differentiation and progenitor depletion, while gain-of-function blocks differentiation, established SIX2 as the key maintenance factor for nephron progenitors opposing Wnt-directed nephrogenesis.\",\n      \"evidence\": \"Loss-of-function mouse genetics and gain-of-function organ culture\",\n      \"pmids\": [\"17036046\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular targets through which SIX2 opposes Wnt signaling not yet identified\", \"Whether SIX2 acts cell-autonomously not formally demonstrated\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Lineage tracing and clonal analysis proved that SIX2-expressing cells are a multipotent, self-renewing nephron progenitor population and that SIX2 functions cell-autonomously, resolving the cellular identity of the progenitor pool.\",\n      \"evidence\": \"Six2-Cre genetic lineage tracing, clonal analysis, conditional knockout, organ culture\",\n      \"pmids\": [\"18682239\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism of self-renewal versus differentiation switch at the chromatin level unresolved\", \"Relationship to other progenitor markers (Osr1, Sall1) not delineated\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Placing Six2 as a direct downstream target of Hoxa2 during branchial arch development revealed that SIX2 operates in a broader Hox-regulated developmental hierarchy beyond the kidney.\",\n      \"evidence\": \"Genetic epistasis and ectopic expression in Hoxa2-mutant mice\",\n      \"pmids\": [\"18321982\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct Hox binding sites in Six2 regulatory region not mapped\", \"Six2 targets in branchial arch mesenchyme unknown\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Dissecting a single Six2 enhancer that is activated by Hox11 in kidney and repressed by Hoxa2 in face showed that tissue-specific Six2 expression is governed by flanking Hox protein domains rather than homeodomain DNA-binding specificity.\",\n      \"evidence\": \"In vivo enhancer analysis with domain-swap mutagenesis in transgenic reporter mice\",\n      \"pmids\": [\"19716816\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Cofactors mediating activation versus repression at the shared enhancer not identified\", \"Whether this enhancer is sufficient for all Six2 kidney expression not tested\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Loss-of-function and gain-of-function studies in the cranial base demonstrated that SIX2 controls chondrocyte proliferation and opposes terminal differentiation, extending its progenitor-maintenance role to skeletal development.\",\n      \"evidence\": \"Six2-null and gain-of-function mouse genetics with histological chondrocyte analysis\",\n      \"pmids\": [\"20515681\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct transcriptional targets in chondrocytes not identified\", \"Relationship to Wnt or other signaling pathways in this context unknown\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"ChIP and co-occupancy analysis showed that SIX2 and β-catenin bind shared cis-regulatory elements at Wnt4/Fgf8 through Lef/Tcf factors, revealing that progenitor self-renewal and Wnt-directed differentiation operate through the same gene regulatory network with opposing transcriptional outcomes.\",\n      \"evidence\": \"ChIP, transcriptional profiling, Lef/Tcf binding site mutagenesis in vivo\",\n      \"pmids\": [\"22902740\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How β-catenin entry into the SIX2–Lef/Tcf complex switches output from maintenance to differentiation is mechanistically unclear\", \"Genome-wide extent of SIX2–β-catenin co-occupancy not fully mapped\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Identifying the Eya1–Six2–Myc interaction established a phosphatase-dependent signaling axis within the progenitor nucleus: Eya1 uses its threonine phosphatase activity on Myc, and Six2 mediates Eya1 nuclear import, linking post-translational modification to progenitor self-renewal.\",\n      \"evidence\": \"Co-immunoprecipitation, conditional knockout, phosphatase activity assay, nuclear translocation assay\",\n      \"pmids\": [\"25458011\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Phosphorylation sites on Myc targeted by Eya1 not mapped\", \"Whether SIX2-dependent Eya1 nuclear translocation requires direct physical interaction or an intermediary not resolved\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Demonstrating that Osr1 and Six2 synergistically prevent differentiation—with Osr1 specifically stabilizing TCF–Groucho repressor complexes—dissected the division of labor among transcription factors maintaining the progenitor state.\",\n      \"evidence\": \"Conditional knockout, Co-IP, Wnt4 enhancer reporter in vivo, epistasis\",\n      \"pmids\": [\"24598167\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether Six2 directly stabilizes TCF–Groucho or acts independently not resolved\", \"Functional redundancy between Six2 and Osr1 at the chromatin level not tested\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Showing that SIX2 represses E-cadherin via Zeb2 upregulation and Cdh1 promoter methylation to drive breast cancer metastasis revealed that SIX2 reactivates developmental EMT programs in cancer.\",\n      \"evidence\": \"Overexpression/knockdown, methylation assays, in vivo metastasis model, epistasis rescue\",\n      \"pmids\": [\"25348955\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether SIX2 directly binds Zeb2 regulatory elements or acts indirectly via miRNAs not fully resolved\", \"Generalizability beyond breast cancer cell lines not established\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Notch signaling was shown to be necessary and sufficient for SIX2 downregulation during nephron progenitor differentiation, placing Notch as an upstream off-switch for the SIX2-maintained progenitor state.\",\n      \"evidence\": \"Conditional gain- and loss-of-function Notch pathway genetics in mouse kidney\",\n      \"pmids\": [\"27993993\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether Notch directly represses Six2 transcription or acts through intermediary factors not determined\", \"Interplay between Notch and Wnt signals at the Six2 locus not clarified\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"ChIP-based identification of Smurf1 and GDNF as direct SIX2 targets in dopaminergic neurons, regulated through an Akt1/Eya1/Six2 phosphorylation cascade, extended the SIX2 functional repertoire to neuroprotection.\",\n      \"evidence\": \"ChIP-seq, ChIP-qPCR, knockdown/overexpression, in vivo 6-OHDA lesion model\",\n      \"pmids\": [\"27148690\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"In vivo relevance of Six2 in dopaminergic neuron survival under physiological conditions not established\", \"Structural basis of Eya1-mediated Six2 dephosphorylation unknown\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Genetic lineage tracing identified SIX2-expressing cells as a dynamic subset of second heart field progenitors whose progressive allocation builds the right ventricle and pulmonary trunk, demonstrating a cardiac developmental role.\",\n      \"evidence\": \"Six2-Cre lineage tracing, conditional cell ablation, Shh deletion epistasis\",\n      \"pmids\": [\"28122228\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Transcriptional targets of SIX2 in cardiac progenitors unknown\", \"Whether SIX2 is required cell-autonomously in heart progenitors not tested\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Haploinsufficiency studies revealed that reducing Six2 dosage paradoxically increases progenitor proliferation and final nephron number via elevated MYC, demonstrating that Six2's self-renewal and proliferation-control functions are separable by gene dosage.\",\n      \"evidence\": \"Quantitative morphometry, EdU labeling, Western blot, transcriptional profiling, Fgf20 epistasis\",\n      \"pmids\": [\"29217079\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Mechanism by which reduced Six2 elevates MYC not determined\", \"Whether this dosage effect is relevant to human nephron endowment variation unknown\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"ChIP demonstrated SIX2 directly binds the Sox2 Srr2 enhancer to activate a Sox2→Nanog stemness cascade in triple-negative breast cancer, establishing a direct transcriptional mechanism for SIX2-driven cancer stem cell maintenance.\",\n      \"evidence\": \"ChIP, enhancer reporter, overexpression/knockdown, in vivo metastasis model in TNBC\",\n      \"pmids\": [\"30606720\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether SIX2 occupancy at Sox2 enhancer requires cofactors (e.g., Eya family) in cancer cells not tested\", \"Relevance to non-breast cancer contexts not established\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Functional studies in stem cell–derived β cells and human islets demonstrated that SIX2 is required for glucose-stimulated insulin secretion, calcium flux, and mitochondrial respiration, revealing an essential role in mature β-cell function distinct from its developmental progenitor role.\",\n      \"evidence\": \"KD/KO in hESC-derived SC-β cells and primary human islets, dynamic insulin secretion, calcium imaging, Seahorse assay, ATAC-seq\",\n      \"pmids\": [\"32460030\", \"33446570\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct SIX2 target genes mediating metabolic and electrophysiological effects in β cells not fully characterized\", \"Whether SIX2 loss affects β-cell identity or only function not resolved\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Identifying SIX2 interaction with the Brg1-SWI/SNF complex and showing that Six2 is required for Brg1 recruitment to nephron progenitor enhancers established a chromatin-remodeling mechanism for SIX2-dependent transcriptional activation.\",\n      \"evidence\": \"Tagged knock-in Co-IP, genome-wide ChIP, in vivo enhancer reporter, conditional knockout\",\n      \"pmids\": [\"34716243\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether SIX2 directly contacts Brg1 or acts through Eya1 as a bridge not resolved\", \"Genome-wide set of SIX2-dependent SWI/SNF-remodeled loci not comprehensively mapped\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Genome-wide binding comparison between Six1 and Six2 showed that Six1 occupies only a small subset of Six2 target sites and fails to rescue proliferation and survival defects in Six2-null kidneys, establishing that paralog-specific binding underlies non-redundant functions.\",\n      \"evidence\": \"Conditional rescue genetics, genome-wide ChIP, cell proliferation/death assays\",\n      \"pmids\": [\"35178390\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Sequence or structural determinants of SIX2-specific binding not identified\", \"Cofactor differences that could explain selective occupancy not explored\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Biochemical identification of TRIM21 as the E3 ligase catalyzing K48-ubiquitination at K82/K89/K97 of SIX2 established the first defined proteolytic regulatory mechanism controlling SIX2 protein levels.\",\n      \"evidence\": \"Co-IP, in vitro ubiquitination assay, K-to-R mutagenesis, proteasome inhibitor rescue\",\n      \"pmids\": [\"40954199\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Signals or conditions triggering TRIM21-mediated SIX2 degradation not identified\", \"Whether this pathway operates in normal development or only in cancer contexts not tested\", \"No structural model of the TRIM21–SIX2 interface\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"A structural basis for SIX2 DNA-binding specificity versus other SIX family members, the complete set of direct transcriptional targets in each progenitor context, and the signaling logic integrating Wnt, Notch, and Eya1 phosphatase inputs at the SIX2 locus remain unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No crystal or cryo-EM structure of SIX2 DNA-binding or protein-interaction domains\", \"Genome-wide direct target validation across developmental and disease contexts incomplete\", \"Quantitative signaling model integrating Wnt, Notch, and phosphorylation inputs on SIX2 activity not constructed\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0003677\", \"supporting_discovery_ids\": [2, 4, 8, 13, 15, 23]},\n      {\"term_id\": \"GO:0140110\", \"supporting_discovery_ids\": [1, 2, 4, 8, 13, 15, 16, 23]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [3, 4, 15, 22]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [2, 5, 6, 19]},\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [0, 1, 9, 10, 18, 21]},\n      {\"term_id\": \"R-HSA-74160\", \"supporting_discovery_ids\": [2, 4, 15, 16]},\n      {\"term_id\": \"R-HSA-4839726\", \"supporting_discovery_ids\": [15]}\n    ],\n    \"complexes\": [\n      \"Brg1-SWI/SNF complex\",\n      \"SIX2–Lef/Tcf complex\"\n    ],\n    \"partners\": [\n      \"EYA1\",\n      \"SMARCA4\",\n      \"SMARCD1\",\n      \"CTNNB1\",\n      \"LEF1\",\n      \"TRIM21\",\n      \"OSR1\",\n      \"EYA4\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}